Director Declaration

Rhea-AI Summary

Shell plc has announced that Cyrus Taraporevala, a Non-executive Director of the company, has been appointed to the Board of Pfizer starting July 1, 2024. This declaration was made in compliance with Listing Rule 9.6.14R(2). Sean Ashley, the Company Secretary, confirmed the appointment. The announcement includes the LEI number of Shell plc, which is 21380068P1DRHMJ8KU70. For further information, the press can contact Shell's international, UK, and European press office at +44 20 7934 5550.

Positive

• Cyrus Taraporevala's appointment to Pfizer's Board may enhance Shell's networking and strategic influence in the pharmaceutical sector.

Negative

• The announcement lacks direct financial or operational benefits for Shell, which may not significantly impact shareholder value.

SHELL PLC

DIRECTOR DECLARATION

Pursuant to Listing Rule 9.6.14R(2), Shell plc (the "Company") confirms that Cyrus Taraporevala, Non-executive Director of the Company, was appointed to the Board of Pfizer Inc. on July 1, 2024.

July 1, 2024

Sean Ashley
Company Secretary

ENQUIRIES
International, UK, European Press: +44 20 7934 5550

LEI number of Shell plc:  21380068P1DRHMJ8KU70

Classification: Additional regulated information required to be disclosed under the laws of a Member State.

FAQ

When was Cyrus Taraporevala appointed to Pfizer's Board?

Cyrus Taraporevala was appointed to Pfizer's Board on July 1, 2024.

What is Shell's LEI number?

Shell's LEI number is 21380068P1DRHMJ8KU70.

Who is the Company Secretary of Shell plc?

Sean Ashley is the Company Secretary of Shell plc.

What rule does the director declaration comply with?

The director declaration complies with Listing Rule 9.6.14R(2).

How can the press contact Shell for more information?

The press can contact Shell's international, UK, and European press office at +44 20 7934 5550.